The UK market remains undervalued despite the FTSE 100’s record surge. Basic materials stocks offer the best value. UK housing stocks, like Persimmon, are considered undervalued. The Morningstar UK Index has gained 18.3% this year, outperforming the US and Eurozone markets.

UK stocks hit record highs in Q4, led by financials and defense sectors. US stocks are overvalued, while UK stocks offer better value with a price/fair value ratio of 0.94. The UK trades at a discount compared to the US and Europe, making it an attractive investment option.

Basic materials, real estate, and healthcare sectors in the UK are undervalued. Basic materials stocks have a price/fair value ratio of 0.82, with healthcare and real estate close behind at 0.85. Key stocks like Glencore and Rio Tinto are undervalued, presenting opportunities for investors to capitalize on potential growth.

UK real estate stocks, including Persimmon, Barratt Redrow, and Taylor Wimpey, are significantly undervalued. The sector trades at a price/fair value ratio of 0.85, offering a greater discount than the broader market. The Autumn Budget in November may impact housing policies and stock performance.

UK healthcare stocks, like GSK, are attractively priced. GSK’s innovative products and strategic focus on oncology and immunology give it a competitive edge. The company’s decision to divest its consumer business in 2022 has been seen as a positive long-term move. GSK’s shift towards true innovation is expected to drive growth and competitiveness in the healthcare sector.

Read more at Morningstar: Is Now a Good Time to Buy UK Stocks?